Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shotaro Korehisa
Clinical Significance of Programmed Cell Death-Ligand 1 Expression and the Immune Microenvironment at the Invasive Front of Colorectal Cancers With High Microsatellite Instability
International Journal of Cancer
Cancer Research
Oncology
Related publications
Clinicopathological Significance and Prognostic Implication of Programmed Death-1 Ligand 2 Expression in Colorectal Cancer
International Journal of Biological Markers
Oncology
Cancer Research
Clinical Biochemistry
Forensic Medicine
Medicine
Pathology
Clinical Significance of Soluble Programmed Cell Death-1 and Soluble Programmed Cell Death-Ligand 1 in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
PLoS ONE
Multidisciplinary
Expression of Programmed Cell Death-Ligand 1 and Its Correlation With Clinical Outcomes in Gliomas
Oncotarget
Oncology
Anti-Programmed Cell Death Protein-1/Ligand-1 Therapy in Different Cancers
British Journal of Cancer
Cancer Research
Oncology
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology
High Density of FOXP3-positive T Cells Infiltrating Colorectal Cancers With Microsatellite Instability
British Journal of Cancer
Cancer Research
Oncology
Antitumor Effects of the Silencing of Programmed Cell Death Ligand�1 in Colorectal Cancer via Immunoregulation
Oncology Reports
Medicine
Cancer Research
Oncology
Programmed Cell Death 4 (Pdcd4) Expression in Colorectal Adenocarcinoma: Association With Clinical Stage
Oncology Letters
Cancer Research
Oncology
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy
JAMA Dermatology
Dermatology
Medicine
